Stabilin‐1/CLEVER‐1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages

Senthil Palani, Mikael Maksimow, Mari Miiluniemi, Kaisa Auvinen, Sirpa Jalkanen, Marko Salmi

European Journal of Immunology (2011)

Published on December 4, 2025

DOI: https://doi.org/10.1002/eji.201041376

Abstract

AbstractStabilin‐1/common lymphatic endothelial and vascular endothelial receptor‐1 (CLEVER‐1) is a multidomain protein present in lymphatic and vascular endothelial cells and type 2 immunosuppressive macrophages. In adults, stabilin‐1/CLEVER‐1 is a scavenging receptor and an adhesion molecule, but much less is known about its role during development. Here, we studied the expression and functions of macrophage stabilin‐1/CLEVER‐1 in human placenta and during human ontogeny. Using newly generated mAbs, we found that stabilin‐1/CLEVER‐1 is expressed on virtually all macrophages in term placenta, both in the decidua and in the placental villi. Placental stabilin‐1/CLEVER‐1 was involved in the scavenging of Ac‐LDL (acetylated low density lipoprotein) and in the uptake of fluorescently labeled model antigen OVA. siRNA‐mediated suppression of stabilin‐1/CLEVER‐1 altered the cytokine profile produced by placental macrophages. Stabilin‐1/CLEVER‐1 on placental macrophages mediated their adhesion to placental vessels and supported their transmigration through vascular endothelium. Finally, we found that stabilin‐1/CLEVER‐1 is induced very early in fetal macrophages, high endothelial venules, and lymphatic vessels in multiple lymphatic organs. Together, these data suggest that macrophage stabilin‐1/CLEVER‐1 can potentially regulate leukocyte migration and scavenging during the development of the placenta and fetus.
← Back to Publications